Document resource
Donald Trump has signed deals with the pharma giants Novo Nordisk and Eli Lilly to lower the prices of antiobesity drugs and get more US citizens taking them.
Annotated abstract
Trump strikes deal with Ozempic and Mounjaro makers to cut prices of obesity injections
bmj · 2025-11-07 · canonical JSON source